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Conclusion: Mean substitution and multiple imputation per-
formed equally well in dealing with missing data generated by
TMA. Complete case analysis, the usual default method for statis-
tical software, resulted in the least accurate and least precise esti-
mates. Given the ease of implementing MS or MI, either approach
should be preferred to CCA.
doi:10.1016/j.ejcsup.2010.06.020
O-20 RATES OF GROWTH OF BREAST CANCER
R.W. Blamey, G. Ball, I.O. Ellis. NottinghamCity Hospital, Nottingham,
UK
Many estimates of growth rate have been published, mostly
theoretical. Here 3 clinically based measurements have been used
to produce curves of growth from inception (one cell) to 7 cm
diameter for each grade.
1. Screening effect – In a trial of screening an excess of tumours
were screen diagnosed by the end of the trial period. Time for
excess to present was calculated as G3 3–6 months, G2 1–
2 years and G1 5–6 years. The mean sizes by method of detec-
tion allowed volume doubling times to be calculated.
2. Occult time for inception to diagnosis – In young women there
is an excess of G3’s and few G1’s. Assuming that inception by
age is constant, graphs of actual detection rates at each age
and of expected allows calculation of the times for which each
grade is occult.
3. Time from primary treatment to death from breast cancer –
Plotting times to death gives medians for G3 167 months, G2
98 and G1 50.
4. As tumours enlarge mitoses become concentrated in the outer
2 mm ‘shell’.1
5. These observations allow curves of volume to be drawn for
each grade from single cell inception from which cell doubling
is assumed, giving a curve increasing logarithmically. From
10 mm diameter growth begins to slow logarithmically with
cell doubling restricted to the outer shell.
Reference:
1. Connor AJM et al. Breast 1997;6:171–6.
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MicroRNAs (miRNAs) are a class of endogenous non-coding
RNAs that target protein coding mRNAs for cleavage or transla-
tional repression. Both profiling and functional studies demon-
strate deranged miRNA expression in many human cancers
including breast tumours. Research in this field is increasing
and the potential of miRNAs for being used in clinical settings
emphasises the need for sensitive detection techniques.
In this study, techniques for the analysis of miRNA expression
in microdissected FFPE breast cancer tissues were developed and
optimised. Full face sections from three invasive breast tumour
samples and different microdissected areas (1000–10 million ll2)
and section thickness (10–20 ll) were analysed. Total RNA was
extracted using commercially available RNA extraction kits
(miRNeasy FFPE Kit, Qiagen; RecoverAlle Total Nucleic Acid Isola-
tion Kit for FFPE, Ambion; PureLink FFPE RNA Isolation Kit, Invit-
rogen). Three miRNAs (miR21: highly expressed, miR-29c:
intermediately expressed, and miR-127: low expression in breast
cancer) extracted from both gross and microdissected invasive
breast cancer tissues were quantified using real-time PCR.
The PureLink kit produced largest quantities of total RNA from
FFPE breast tumours. All three miRNA (21, 29c and 127) were suc-
cessfully detected by real-time PCR and levels of sensitivity were
comparable between extraction methods. Our data showed that
relative miRNA levels gradually decreased with diminishing
amounts of microdissected tissue used but reliable miRNA quan-
tification was obtained using at least 5 million ll2 from 20 ll thick
FFPE breast tissue sections.
In contrast to previously published results, quantity of miRNA
detected in breast tissue samples depends on the amount of tis-
sue used, and cannot be performed reliably from one or a few
cells.
doi:10.1016/j.ejcsup.2010.06.022
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RITHM TO ANALYSE THE INTERACTION PATTERNS EXISTING IN
GENE MICROARRAYS: AN APPLICATION TO BREAST CANCER
GENOMIC DATA
Christophe Lemetre, Lee James Lancashire, Graham Roy Ball.
Nottingham Trent University, UK
Genomic array technologies, by allowing the assessment of
the level of expression of thousands of genes simultaneously in
the same experiment, have brought the hope to identify new bio-
markers related to particular outcome in disease. The majority of
the research conducted to date with gene microarrays has only
been focusing on this biomarker discovery. However, these arrays
hold the inherent information of gene co-expression patterns and
only few groups have focused their attention toward deciphering
such network of interactions and regulation.
We present here a novel approach based on Artificial Neural
Network technology to further analyse the data extracted from
gene array experiments. This approach has been applied to a
well-known breast cancer dataset publicly available.1 The results
showed interesting patterns of interactions or gene regulation,
and some of them could be confirmed by alternative methods,
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